To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.

The Congressional Research Service hasn't published a summary of this bill yet. They usually follow within weeks of introduction.

Our plain-language breakdown, with what it means for you and the case for and against, is written once a bill starts to move.

1. Oct 29, 2026Introduced in HouseLibrary of Congress

Show all 3 recorded actions

Cosponsors

• Becca Balint D-VT-At Large
• Emanuel Cleaver D-MO-5
• Sharice Davids D-KS-3
• Jared F. Golden D-ME-2
• Pablo José Hernández D-PR-At Large
• Tracey Mann R-KS-1
• Seth Moulton D-MA-6
• Dan Newhouse R-WA-4
• Eleanor Holmes Norton D-DC-At Large
• Raul Ruiz D-CA-25
• Austin Scott R-GA-8
• Melanie A. Stansbury D-NM-1